Supreme Court skeptical of Myriad s gene patents
Can you patent a human gene? The Supreme Court today seemed skeptical, raising questions about the legality of Myriad Genetic’s isolation of the BRCA1 and BRCA2 genes that signal an increased risk of breast and ovarian cancer. It’s a complex issue. Companies can’t patent abstract ideas, natural phenomena and laws of nature. But an appeals [...]
The post Supreme Court skeptical of Myriad’s gene patents appeared first on Health & Science Dispatch.
